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Introduction 
 
Neurological cancer and other neurodegenerative diseases are amongst the 
most crippling illnesses with the greater portion of infected individuals not 
projected to survive past five years of initial diagnosis depending on the 
severity, stage, and form of the disease; the research in this project will 
identify the neurological molecular mechanisms of specific biological 
markers increasingly found to be identified in instances of these diseases, 
specifically c Jun kinase, which upon identification will be inhibited by 
utilizing SAB antibodies. Consequently, further damage such as mutation in 
the mitochondrial DNA and stress including cascades of apoptotic signaling 
pathways will be entirely halted, providing a highly effective treatment to 
the aforementioned neurodegenerative diseases.  
 
Hypothesis  
 
I propose that upon further research with the interaction of SAB and c Jun 
kinase, that there will be a highly interdependent molecular reaction revealed 
that links the inhibition of JNK kinase to the presence of the SAB, or 
SH3BP5, gene.  
 
Methods 
 
The major methods that I will use throughout the course of this research 
includes the use of the Western Blot Protocol in conjunction with the 
extensive cell culture of brain cancer cell lines including JNK and wild-type. 
This protocol will utilize specific proteins from these cell lines and blot them 
with antibodies of common mitochondrial outer membrane mediators. The 
proteins will first be ran through a selective membrane via gel 
electrophoresis that allows for progressive movement based on molecular 
weight; increased weight produces greater facility in movement on the 
membrane. Under specific radiation, these will fluoresce in order to provide 
a correlation or lack thereof between the protein and antibody. 
 
Significance 
 
My project is innovative in that it will provide further insight into the very 
nature of the interaction of JNK and SAB, seeking to develop a SAB isotope 
that will effectively inhibit JNK kinase. This may provide an effective 
treatment to terminate neurodegenerative disease by inhibiting a major 
stressor in order to prevent further mutation or dysfunction in molecular 
mechanisms associated with numerous neurodegenerative diseases.  
 
